+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a new preoperative ophthalmic solution



Evaluation of a new preoperative ophthalmic solution



Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 40(1): 58-62



Maximum mydriasis and corneal clarity during intraocular surgery are important to ensure operational safety. However, repeated instillation of mydriatic and anti-inflammatory ophthalmic solutions during surgery may affect compliance and may damage the corneal epithelium. We developed an ophthalmic solution containing tropicamide, phenylephrine hydrochloride and diclofenac sodium, and compared the properties and effect on corneal epithelial barrier function and on mydriasis of the solution and of its individual components. We developed the ophthalmic solution by mixing 10 mL of 0.5% tropicamide/0.5% phenylephrine, 10 mL of 5% phenylephrine and 10 mL of 0.1% diclofenac (TPD). We determined the stability of the chemicals in solution using high-performance liquid chromatography immediately, 1 week and 1 month after mixing. Corneal epithelial barrier function was assessed before and after instillation of the solutions in 26 eyes of 17 patients (5 with proliferative diabetic retinopathy or diabetic maculopathy, 8 with cataract and 4 with no eye disease). The fluorescent intensity was measured 10 times at the central cornea 30 minutes after instillation of 3 mL of 0.5% fluorescein solution and the average value calculated. Finally, the pupil diameter of 50 eyes of 38 patients undergoing cataract surgery was measured before and immediately after the operation. No remarkable changes in the pH or pharmacologic activity of the TPD solution were observed at any time after mixing. In the patients with diabetic retinopathy or cataract, the increase in mean fluorescent intensity was significantly greater with the individual solutions than with the TPD solution (p < 0.01); there was no significant difference in mean fluorescent intensity in the subjects with no eye disease. No statistically significant difference in pupil diameter was observed between the eyes that received the TPD solution and those that received the individual solutions. TPD ophthalmic solution is simple to prepare and use. The TPD solution had a similar effect on mydriasis as the three individual solutions but was less destructive to the corneal epithelium.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048993707

Download citation: RISBibTeXText

PMID: 15825531

DOI: 10.1016/s0008-4182(05)80118-8


Related references

Comparative evaluation of olopatadine ophthalmic solution versus ketorolac ophthalmic solution using the provocative antigen challenge model. Acta Ophthalmologica Scandinavica Suppl. 0(228): 47-52, 1999

Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model. Acta Ophthalmologica Scandinavica. Supplement: 47-52, 1999

Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clinical Ophthalmology 5: 1451-1457, 2011

Clinical evaluation of dipivefrin hydrochloride ophthalmic solution for primary open angle glaucoma and ocular hypertension comparison with epinephrine ophthalmic solution. Rinsho Ganka 40(9): 1089-1106, 1986

Efficacy and safety evaluation of lodoxamide 01 percent ophthalmic solution vs cromolyn sodium 4 percent ophthalmic solution in patients with vernal keratoconjunctivitis vkc. Investigative Ophthalmology & Visual Science 32(4): 736, 1991

Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model. Clinical Therapeutics 23(8): 1272-1280, 2001

An ocular comfort comparison of 01% pemirolast potassium ophthalmic solution with 4% sodium cromolyn ophthalmic solution and 05% ketorolac tromethamine ophthalmic. Journal of Allergy & Clinical Immunology 107(2): S215, 2001

Availability of TPD ophthalmic solution (mixture of Mydrin-P solution, Neosynesin Kowa solution, and Diclod solution) in regard to the corneal barrier function--clinical evaluation for vitrectomy in patients with diabetic retinopathy. Nippon Ganka Gakkai Zasshi 106(10): 648-653, 2002

Prospective clinical evaluation of 1.5% levofloxacin ophthalmic solution in ophthalmic perioperative disinfection. Journal of Ocular Pharmacology and Therapeutics 29(10): 887-892, 2013

A pilot, multi-center evaluation of 05% levofloxacin ophthalmic solution, a new ophthalmic fluoroquinolone. IOVS 40(4): S689, 1999

Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. Journal of Ocular Pharmacology and Therapeutics 22(4): 251-257, 2006

In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits. Ophthalmology and Therapy 7(1): 157-165, 2018

Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis. Current Medical Research and Opinion 27(1): 171-178, 2011

Study of sisomicin ophthalmic solution used alone for preoperative sterilization and prevention of postoperative infection. Folia Ophthalmologica Japonica 37(6): 943-954, 1986

A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Ophthalmology 110(3): 457-465, 2003